|
SE9603726D0
(sv)
*
|
1996-10-11 |
1996-10-11 |
Astra Ab |
Novel compounds
|
|
JP2002502831A
(ja)
*
|
1998-02-03 |
2002-01-29 |
イネックス ファーマシューティカルズ コーポレイション |
癌の治療に用いる血清に対して安定なプラスミド脂質粒子の全身供与
|
|
US6410328B1
(en)
|
1998-02-03 |
2002-06-25 |
Protiva Biotherapeutics Inc. |
Sensitizing cells to compounds using lipid-mediated gene and compound delivery
|
|
IL131887A0
(en)
*
|
1999-09-14 |
2001-03-19 |
Dpharm Ltd |
Phospholipid prodrugs of anti-proliferative drugs
|
|
EP1244459A2
(en)
*
|
1999-12-29 |
2002-10-02 |
The Regents of the University of California |
Treatment of drug-resistant human immunodeficiency virus infection
|
|
EP1460082A1
(en)
*
|
2003-03-19 |
2004-09-22 |
Heidelberg Pharma Holding GmbH |
Phospholipid esters of clofarabine derivatives
|
|
EP1838283B1
(en)
*
|
2004-11-03 |
2008-12-31 |
Liplasome Pharma A/S |
Lipid-based drug delivery systems containing unnatural phospholipase a2 degradable lipid derivatives and the therapeutic uses thereof
|
|
CN101094677A
(zh)
|
2004-11-15 |
2007-12-26 |
塞普泰尔公司 |
蛋白酪氨酸磷酸酶抑制剂及其使用方法
|
|
WO2006066074A2
(en)
*
|
2004-12-16 |
2006-06-22 |
The Regents Of The University Of California |
Lung-targeted drugs
|
|
AU2007229160A1
(en)
*
|
2006-03-23 |
2007-09-27 |
Liplasome Pharma A/S |
Lipid based drug delivery systems comprising phospholipase A2 degradable lipids that perform an intramolecular cyclization reaction upon hydrolysis
|
|
ES2600792T3
(es)
*
|
2006-05-03 |
2017-02-10 |
Chimerix, Inc. |
Alcoxialquilésteres metabólicamente estables de fosfonatos, fosfonatos nucleosídicos y fosfatos nucleosídicos antivirales o antiproliferativos
|
|
JP5620272B2
(ja)
*
|
2007-11-09 |
2014-11-05 |
プロノヴァ・バイオファーマ・ノルゲ・アーエスＰｒｏｎｏｖａ ＢｉｏＰｈａｒｍａ ＮｏｒｇｅＡＳ |
化粧品において，食品サプリメントとして，または医薬品として用いるための脂質化合物
|
|
EP2070938A1
(en)
*
|
2007-12-13 |
2009-06-17 |
Heidelberg Pharma AG |
Clofarabine dietherphospholipid derivatives
|
|
JP2011508740A
(ja)
*
|
2007-12-27 |
2011-03-17 |
エピファニー バイオサイエンシズ， インク． |
抗ウイルス化合物
|
|
US8586625B2
(en)
*
|
2008-01-16 |
2013-11-19 |
Anwar Rayan |
Derivatives of taxol and closely related compounds
|
|
EP2147910A1
(en)
*
|
2008-07-15 |
2010-01-27 |
Pronova BioPharma Norge AS |
Novel lipid compounds
|
|
SG175401A1
(en)
|
2009-05-08 |
2011-12-29 |
Pronova Biopharma Norge As |
Polyunsaturated fatty acids for the treatment of diseases related to cardiovascular, metabolic and inflammatory disease areas
|
|
US8884027B2
(en)
|
2010-10-22 |
2014-11-11 |
University Of Rochester |
Melampomagnolide B derivatives as antileukemic and cytotoxic agents
|
|
MY170076A
(en)
|
2010-11-05 |
2019-07-03 |
Pronova Biopharma Norge As |
Methods of treatment using lipid compounds
|
|
WO2014132134A1
(en)
|
2013-02-28 |
2014-09-04 |
Pronova Biopharma Norge As |
A composition comprising a lipid compound, a triglyceride, and a surfactant, and methods of using the same
|
|
EA201892769A3
(ru)
|
2013-03-15 |
2019-08-30 |
Дзе Риджентс Оф Дзе Юниверсити Оф Калифорния |
Сложные диэфиры ациклических нуклеозидфосфонатов
|
|
RU2665135C2
(ru)
|
2014-03-14 |
2018-08-28 |
Олтек, Инк. |
Композиции селеноорганических соединений и способы их применения
|
|
BR112017005111B1
(pt)
|
2014-09-15 |
2023-02-14 |
The Regents Of The University Of California |
Compostos análogos de nucleotídeo acíclico, composição farmacêutica contendo tais compostos, e usos da composição no tratamento de uma infecção por papilomavírus
|
|
CA2968790A1
(en)
|
2014-11-26 |
2016-06-02 |
Vascular Biogenics Ltd. |
Oxidized lipids and treatment or prevention of fibrosis
|
|
US9771385B2
(en)
|
2014-11-26 |
2017-09-26 |
Vascular Biogenics Ltd. |
Oxidized lipids
|
|
CA3182565A1
(en)
|
2015-03-06 |
2016-09-15 |
Atea Pharmaceuticals, Inc. |
.beta.-d-2'-deoxy-2'-.alpha.-fluoro-2'-.beta.-c-substituted-2-modified-n6-substituted purine nucleotides for hcv treatment
|
|
BR112017023164A2
(en)
|
2015-04-28 |
2018-07-24 |
Pronova Biopharma Norge As |
and method of preventing and / or treating non-alcoholic steatohepatitis in an individual in need thereof
|
|
WO2017048252A1
(en)
|
2015-09-15 |
2017-03-23 |
Alltech, Inc. |
Compositions of selenoorganic compounds and methods of use thereof
|
|
WO2017048956A1
(en)
|
2015-09-15 |
2017-03-23 |
The Regents Of The University Of California |
Nucleotide analogs
|
|
US10711029B2
(en)
|
2016-07-14 |
2020-07-14 |
Atea Pharmaceuticals, Inc. |
Beta-d-2′-deoxy-2′-alpha-fluoro-2′-beta-c-substituted-4′fluoro-n6-substituted-6-amino-2-substituted purine nucleotides for the treatment of hepatitis c virus infection
|
|
DK3512863T3
(da)
|
2016-09-07 |
2022-03-07 |
Atea Pharmaceuticals Inc |
2¿-substituerede-N6-substituerede purinnukleotider til behandling af RNA-virus
|
|
HRP20241643T1
(hr)
|
2017-12-06 |
2025-02-14 |
Basf As |
Derivati masnih kiselina za liječenje nealkoholnog steatohepatitisa
|
|
JP7610208B2
(ja)
*
|
2019-03-22 |
2025-01-08 |
インテグレイテッド ナノセラピューティクス インコーポレイテッド |
足場部分から調製した脂質結合体
|
|
AU2020334152A1
(en)
|
2019-08-22 |
2022-03-24 |
Emory University |
Nucleoside prodrugs and uses related thereto
|
|
WO2021173713A1
(en)
|
2020-02-27 |
2021-09-02 |
Atea Pharmaceuticals, Inc. |
Highly active compounds against covid-19
|
|
US10874687B1
(en)
|
2020-02-27 |
2020-12-29 |
Atea Pharmaceuticals, Inc. |
Highly active compounds against COVID-19
|
|
AU2021330835B2
(en)
|
2020-08-24 |
2023-12-14 |
Gilead Sciences, Inc. |
Phospholipid compounds and uses thereof
|
|
TW202344257A
(zh)
|
2020-10-16 |
2023-11-16 |
美商基利科學股份有限公司 |
磷脂化合物及其用途
|
|
IL318465A
(en)
|
2022-07-21 |
2025-03-01 |
Antiva Biosciences Inc |
Compositions and dosage forms for the treatment of HPV infection and HPV-induced neoplasia
|